JOHNSON & JOHNSON (JNJ) Analyst Ratings
JNJ Analyst Consensus & Price Target
JOHNSON & JOHNSON (JNJ) carries a consensus rating of Strong Buy from 9 analysts on record (Dec 10, 2024 to May 13, 2026): 7 bullish, 1 neutral, 0 bearish. The average price target is $224.25 (range $166.00 to $265.00), with wide disagreement among analysts. That implies +16.3% downside from the current price of $268.04. Recent activity leans toward upgrades: 6 upgrades vs 1 downgrade on record. The price target on record has moved from $166.00 to $265.00 (+59.6%) between Dec 10, 2024 and May 13, 2026.
One vote per analyst, using each firm's most recent rating on record, not every historical reiteration counted separately.
1 rating(s) used a label we did not recognize and are not counted in the breakdown above.
Each analyst's most recent target on record, compared against where the stock actually trades. See how actual results have compared to estimates →
Is the average price target keeping pace with the stock, running ahead of it, or lagging behind? Compares the target's overall drift on record (across different analysts) to the stock's own move over the same window.
The stock has moved faster than analysts have updated their targets, targets may be playing catch-up.
Every rating on record, most recent first. "Next-close move" is the stock's own move from the prior close to the rating date's close, where price history lines up, a data point per event, not an averaged claim.
| Date | Analyst | Action | Rating | Price Target | Move |
|---|---|---|---|---|---|
| May 13, 2026 | Leerink Partners | Upgrade | Market Perform to Outperform | $265 | +2.75% |
| Apr 8, 2026 | TD Cowen | Resumed | Buy | $250 | +1.21% |
| Jan 28, 2026 | Morgan Stanley | Upgrade | Equal-Weight to Overweight | $262 | +1.46% |
| Nov 13, 2025 | Scotiabank | Initiated | Sector Outperform | $230 | +0.44% |
| Oct 20, 2025 | Daiwa Securities | Upgrade | Neutral to Outperform | $203 | +0.26% |
| Oct 3, 2025 | Wells Fargo | Upgrade | Equal Weight to Overweight | $212 | +1.43% |
| Sep 23, 2025 | Guggenheim | Upgrade | Neutral to Buy | $206 | +1.36% |
| Jul 23, 2025 | Erste Group | Upgrade | Hold to Buy | — | +0.70% |
| May 13, 2025 | Leerink Partners | Downgrade | Outperform to Market Perform | $153 | -3.70% |
| Dec 10, 2024 | BofA Securities | Resumed | Neutral | $166 | -0.25% |
What is the analyst consensus rating for JNJ?
JOHNSON & JOHNSON's consensus rating is Strong Buy, based on 9 analysts' most recent ratings on record: 7 bullish, 1 neutral, 0 bearish.
What is JNJ's average analyst price target?
The average price target on record is $224.25, ranging from $166.00 to $265.00 across 8 analysts, wide disagreement. That implies -16.3% from the current price of $268.04.
Are analysts upgrading or downgrading JNJ right now?
On record between Dec 10, 2024 and May 13, 2026: 6 upgrades, 1 downgrade, 1 new initiation, and 0 reiterations.
Are analyst price targets for JNJ rising or falling?
The price target on record moved from $166.00 on Dec 10, 2024 to $265.00 on May 13, 2026, a change of +59.6%. This compares different analysts over time, not one analyst's revision.
How many analysts cover JNJ?
9 analysts have rated JNJ in the data on record, spanning Dec 10, 2024 to May 13, 2026.